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ABSTRACT
Insects are a reservoir for many known and novel viruses. We discovered an unknown virus, tentatively named mosinovirus (MoNV),
in mosquitoes from a tropical rainforest region in Côte d’Ivoire. The MoNV genome consists of two segments of positive-sense RNA of
2,972 nucleotides (nt) (RNA 1) and 1,801 nt (RNA 2). Its putative RNA-dependent RNA polymerase shares 43% amino acid identity
with its closest relative, that of the Pariacoto virus (family Nodaviridae). Unexpectedly, for the putative capsid protein, maximal
pairwise identity of 16% to Lake Sinai virus 2, an unclassified virus with a nonsegmented RNA genome, was found. Moreover,
MoNV virions are nonenveloped and about 50 nm in diameter, larger than any of the known nodaviruses. Mature MoNV virions
contain capsid proteins of56 kDa, which do not seem to be cleaved from a longer precursor. Northern blot analyses revealed
that MoNV expresses two subgenomic RNAs of 580 nt (RNA 3) and 292 nt (RNA 4). RNA 4 encodes a viral suppressor of RNA
interference (RNAi) that shares its mechanism with the B2 RNAi suppressor protein of other nodaviruses despite lacking recog-
nizable similarity to these proteins. MoNV B2 binds long double-stranded RNA (dsRNA) and, accordingly, inhibits Dicer-2-me-
diated processing of dsRNA into small interfering RNAs (siRNAs). Phylogenetic analyses indicate that MoNV is a novel member
of the family Nodaviridae that acquired its capsid gene via reassortment from an unknown, distantly related virus beyond the
family level.
IMPORTANCE
The identification of novel viruses provides important information about virus evolution and diversity. Here, we describe an
unknown unique nodavirus in mosquitoes, named mosinovirus (MoNV). MoNV was classified as a nodavirus based on its ge-
nome organization and on phylogenetic analyses of the RNA-dependent RNA polymerase. Notably, its capsid gene was acquired
from an unknown virus with a distant relationship to nodaviruses. Another remarkable feature of MoNV is that, unlike other
nodaviruses, it expresses two subgenomic RNAs (sgRNAs). One of the sgRNAs expresses a protein that counteracts antiviral de-
fense of its mosquito host, whereas the function of the other sgRNA remains unknown. Our results show that complete genome
segments can be exchanged beyond the species level and suggest that insects harbor a large repertoire of exceptional viruses.
The ongoing identification of novel viruses in insects illustratesthe fact that our understanding of virus diversity is far from
complete. The characterization of novel viruses provides impor-
tant new insights into genome organization and replication strat-
egies. For example, a new nidovirus family named Mesoniviridae
has recently been identified in mosquitoes (1, 2), and it uses a
uniquemechanism to generate subgenomic RNAs and express the
spike glycoprotein (3). Another example is the discovery of clades
of putatively insect-specific bunyaviruses with less complex ge-
nomes than vertebrate-infecting bunyaviruses, suggesting that
they encode only the basic genes necessary for virus maintenance
in insects (4, 5). Furthermore, novel viruses with a bipartite posi-
tive-sense RNA genome, chronic bee paralysis virus (CBPV) and
anopheline-associated C virus (AACV), were identified in bees
and mosquitoes, respectively (6, 7). These viruses are distantly
related tomembers of the familyNodaviridae andmay comprise a
novel virus family. Lake Sinai virus 1 (LSV1) and LSV2 are two
novel monopartite, positive-sense RNA viruses identified in hon-
eybees (8). They are distantly related tomembers of themonopar-
tite family Tombusviridae, as well as to CBPV and AACV, suggest-
ing that they also belong to a novel virus family.
The family Nodaviridae contains two established genera, Al-
phanodavirus and Betanodavirus, which infect insects and fish,
respectively. Although alphanodaviruses naturally infect only in-
sects, their RNAs can replicate in vertebrate (9, 10), plant (11), and
yeast (12) cells. Betanodaviruses cause significant problems inma-
rine fish aquacultures worldwide (13). Recently, three further clades
of unclassified nodaviruses infecting moths and butterflies (14–17),
nematodes (18), and prawns (19) were identified. These clades are only
distantly related to the alpha- andbetanodaviruses (also seebelow), sug-
gesting that they may represent new genera within the Nodaviridae.
These findings suggest that the Nodaviridae family comprises
members with wide distribution in metazoans.
Received 21 July 2014 Accepted 2 September 2014
Published ahead of print 10 September 2014
Editor: D. S. Lyles
Address correspondence to Ronald P. van Rij, R.vanRij@ncmls.ru.nl, or Sandra
Junglen, junglen@virology-bonn.de.
S.S. and F.Z. contributed equally to this work.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JVI.02144-14
November 2014 Volume 88 Number 22 Journal of Virology p. 13447–13459 jvi.asm.org 13447
 o
n
 M
arch 6, 2017 by UNIVERSITEITSBIBLIO
THEEK
http://jvi.asm.org/
D
ow
nloaded from
 
The nonenveloped nodavirus virions are30 nm in diameter
and contain a bipartite positive-sense RNA genome (for a review,
see reference 20). Both RNA segments are 5= capped, while their 3=
ends lack a poly(A) tail. RNA 1 (3 kb) encodes protein A (102
kDa), the RNA-dependent RNA polymerase (RdRp). RNA 2
(1.5 kb) encodes the capsid precursor protein , which is auto-
catalytically cleaved into the viral capsid proteins (38 kDa) and
(5 kDa) during particle maturation of alphanodaviruses (21). Au-
tocatalytic cleavage of the capsid protein is required for virion
stability and infectivity of alphanodaviruses (22) but does not oc-
cur in betanodaviruses (23). Other unclassified nodaviruses, like
Wuhan nodavirus (WhNV), contain a major and a minor capsid
protein of 40 and 44 kDa, respectively (24).
During nodavirus RNA replication, a subgenomic RNA, RNA
3, is synthesized from the 3= terminus of RNA 1. RNA 3 encodes
one or two proteins (B1 and B2) in overlapping ORFs (25–27).
The B2 protein is essential for evading antiviral RNA interference
(RNAi) responses (28–32). RNAi is a crucial antiviral defense sys-
tem in insects (33, 34). Antiviral RNAi is activated by viral double-
stranded RNA (dsRNA), which is processed into viral small inter-
fering RNAs (vsiRNAs) of 21 nucleotides (nt) by the RNase
Dicer-2 (Dcr-2) (28, 29, 35–45). The current model proposes that
these vsiRNAs are loaded onto Argonaute-2 (AGO2) in the RNA-
induced silencing complex (RISC) to guide the recognition and
cleavage of viral target RNA by AGO2, thereby restricting viral
replication (29, 33, 37, 38, 46–48). Indeed, fruit flies deficient in
Dicer-2, its cofactor R2D2, and AGO2 are hypersensitive to virus
infection and support higher levels of viral replication than wild-
type flies (32, 35–38, 48, 49). Similarly, knockdown of crucial
RNAi genes, such as Dcr-2 and AGO2, in mosquitoes results in
higher titers of different viruses (50–52).
Nodaviruses are an attractive system for studying antiviral
RNAi responses and viral counterdefensemechanisms. For exam-
ple, using Flock House virus (FHV) as a model, it was shown for
the first time that insect viruses may encode virus-encoded sup-
pressors of RNAi (VSRs) (30). FHV B2 interferes with multiple
steps of the RNAi pathway. B2 has dsRNA binding activity, and it
was proposed that this prevents Dicer from processing dsRNA
into siRNAs (53–55). In addition, FHV B2 binds to Dcr-2, which
might affect its processing activity (56). Moreover, B2 binds
siRNAs, thereby preventing their incorporation into RISC (53–
55). Importantly, a FHV mutant that lacks B2 expression (B2)
has severe replication defects in RNAi-competent hosts but not in
RNAi-deficient systems, indicating that suppression of antiviral
RNAi is the main function of B2 (28, 29, 32). Members of other
insect virus families also encode VSRs. For example, Drosophila C
virus 1A inhibits RNAi by binding long dsRNA (48), Drosophila X
virus and Culex Y virus VP3 have dsRNA and siRNA binding
activity (57), whereas Nora virus VP1 and cricket paralysis virus
(CrPV) 1A suppress RNAi by antagonizing the catalytic activity of
AGO2 (32, 47, 58, 59).
To gainmore insight into virus-mosquito interactions, we sur-
veyed wild-caught mosquitoes for unknown viruses. Here, we re-
port the isolation of an atypical nodavirus from mosquitoes, ten-
tatively named mosinovirus (MoNV, for mosquito nodavirus).
MoNV was sampled in a tropical rainforest region in Côte
d’Ivoire. We analyzed the complete genome, inferred the phylo-
genetic relationships, investigated virion morphology and viral
structural proteins, characterized the subgenomic RNAs, and
tested the ability of MoNV to suppress the host RNAi response.
MATERIALS AND METHODS
Cell culture. Drosophila S2 cells (Invitrogen) and S2 R cells (60) were
cultured at 25°C in Schneider’s medium (Invitrogen) supplemented with
10% heat-inactivated fetal calf serum (PAA), 50 U/ml penicillin, and 50
mg/ml streptomycin (Invitrogen).Aedes albopictus-derivedU4.4 (61) and
C6/36 (62) cells were cultured at 28°C in Leibovitz’smedium (Invitrogen)
supplemented with 10% heat-inactivated fetal calf serum, 50 U/ml peni-
cillin, 50 mg/ml streptomycin (Invitrogen), 1% modified Eagle medium
(MEM) with nonessential amino acids (Invitrogen), and 2% tryptose
phosphate broth solution (Sigma-Aldrich). Vero E6 and BHK-J cells were
cultured at 37°C with 5% CO2 in Dulbecco’s modified Eagle medium
(DMEM) (Invitrogen) supplemented with 10% fetal calf serum and 2%
L-glutamine.
Virus isolation, purification, and protein analyses. Virus isolation
from mosquitoes was performed in C6/36 cells as described previously
(63, 64). Briefly,mosquitoes were stored in liquid nitrogen in the field and
at80°C in the laboratory until further analysis. For virus isolation trials,
mosquitoes were pooled and homogenized in DMEM without additives.
Aliquots were cleared from debris by centrifugation, and subconfluent
cells seeded were infected with supernatants in 24-well plates. Cells were
monitored daily for signs of cytopathic effects (CPE). An aliquot of the
supernatant (1:10 dilution) was used to infect fresh cells when 80% of the
cells showed CPE. A stock of the third passage of MoNV (isolate C36/CI/
2004) was prepared. Virus titers were determined by 50% tissue culture
infective dose (TCID50) titration in C6/36 cells. Virus-positive wells were
identified by observation of cytopathic effects. Virions were concentrated
from the supernatant of one T175 flask of infected C6/36 cells by ultra-
centrifugation through a 36% (wt/vol) sucrose cushion. The virus pellet
was resuspended in 200 	l phosphate-buffered saline (PBS) at 4°C over-
night (63). For the analyses of the protein content of viral particles,MoNV
virions were purified by gradient ultracentrifugation on a continuous gra-
dient of 1 to 2M sucrose in 0.001M Tris-HCl-4 mMEDTA, and proteins
were analyzed by SDS-PAGE as described previously (5).
Electron microscopy. For electron microscopy (EM), an aliquot of
purified, concentrated virus (10	l) was fixed with 2% paraformaldehyde
and processed for direct negative-staining electron microscopy (65, 66).
The samplewas contrastedwith 1%uranyl acetate and examined by trans-
mission electron microscopy.
Virus growth kinetics. C6/36 and U4.4 cells were infected at an mul-
tiplicity of infection (MOI) of 0.001 in duplicate in two independent ex-
periments as described previously (1). Aliquots of cell culture supernatant
were harvested at 1 h postinfection (hpi) and then every 24 hpi for a period
of 5 days. Vero E6 and BHK-J cells were infected at MOIs of 0.01 and 0.1
in duplicate, and aliquots of cell culture supernatant were harvested at 1
hpi and 7 days postinfection (dpi). RNA was extracted using the Nucle-
oSpin RNA virus kit (Macherey-Nagel), and cDNAwas synthesized using
the SuperScript III RT system (Life Technologies) and random hexamer
primers. Viral genome copy numbers were quantified by real-time RT-
PCR using the primers MoNV-F (5=-GAGTACGTCGAGGCGGTGAT-
3=) andMoNV-R (5=-CGCGGATGGTGTCATTAGTG-3=) and the probe
MoNV-TM (5=-6-carboxyfluorescein [FAM]-AGCCGCCCCGTTAAGC
TACGCC-TQ2).
Unbiased ultradeep sequencing.Deep sequencingwas performed us-
ing theGS-Junior platform (Roche) following themanufacturer’s instruc-
tions. Briefly, RNA was extracted from purified virus pellets using TRIzol
LS reagent (Life Technologies). Double-stranded cDNA was generated
using a cDNA synthesis system (Roche) with random hexamer primers.
The cDNA was fragmented via liquid nitrogen nebulization, followed by
adapter ligation, emulsion PCR, and 454 pyrosequencing according to the
manufacturer’s instructions. After trimming of primer sequences, the
reads were clustered and assembled into contiguous fragments (contigs)
using Geneious 6 (67). Consensus sequences and unassembled reads (nu-
cleotide and translated amino acid sequences) were compared to the Gen-
Bank database using Basic Local Alignment Search Tool (BLASTn,
BLASTp, BLASTx, and tBLASTx). Reads and contigs that showed simi-
Schuster et al.
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larity to viral sequences were referencemapped to all reads with iterations
up to five times.
Genome sequencing and analysis. Sequence contigs obtained by 454
pyrosequencing were confirmed with standard PCR with Platinum Taq
DNA polymerase (Life Technologies) and contig-specific primers. The 5=
and 3= genome termini were analyzed by rapid amplification of cDNA
ends (RACE) (Life Technologies). RACE PCR products were cloned into
the TopoTA pCR4 cloning vector (Life Technologies) and Sanger se-
quenced (SeqLab). Sequences were analyzed using Geneious 6 (67). The
complete genomewas confirmed by long-range PCR and Sanger sequenc-
ing on both strands. The 5= ends of the subgenomic mRNAs were ampli-
fied with gene-specific primers for ORF2 and -3 from RNA 1 using the
GeneRacer kit (Life Technologies) according to the manufacturer’s in-
structions. Products were sequenced and analyzed using Geneious 6 (67).
Phylogenetic analysis. Amino acid sequences of RdRp and capsid
proteins were aligned using MAFFT (68) and the E-INS-I algorithm in
Geneious 6 (67). Phylogenetic analyses were conducted by using themax-
imum likelihood (ML) algorithm with the Dayhoff substitution model,
four gamma categories, and no optimization with 1,000 bootstrap repli-
cates using MEGA v5 (69).
RNA analyses. Northern blot analyses of viral RNAs were performed
as described previously (3). Briefly, C6/36 cells were infected with MoNV
and harvested at 24 hpi. RNA was extracted using the RNeasy minikit
(Qiagen) and analyzed by Northern blotting with digoxigenin (DIG)-
labeled probes. Probes for protein A (ORF1, RNA 1), protein B2 (ORF3,
RNA 1), and the capsid protein (ORF1, RNA 2) were generated using the
PCR DIG probe synthesis kit (Roche) and the gene-specific primer pairs
MoNV-A-F (5=-GGTGGTCAGCAACGAGTGAA-3=) and MoNV-A-R
(5=-TTGTGGCTGCTTCCTTGTCA-3=), MoNV-B2-F (5=-AGAAAATC
AGCAGCAACTTCGG-3=) and MoNV-B2-R (5=-TCACTTCGCTTCGA
CGATGG-3=), and MoNV-C-F (5=-CCGGATACAACATCGACGACCC
C-3=) and MoNV-C-R (5=-ACTCGCGACAGGTTTGATGACACT-3=),
respectively.
Plasmids. The following plasmids were described previously: pMT-
Luc and pMT-Ren (48), pAWH-CrPV1A (32, 58), and pAc-DXV VP3
(57). To cloneMoNVB2 into an insect expression plasmid, total RNAwas
isolated fromMoNV-infected C6/36 cells using Isol-RNA lysis reagent (5
Prime) and reverse transcribed into cDNA using TaqMan reverse tran-
scription reagents (Roche) and random hexamers (Roche). The MoNV
B2 ORF was PCR amplified using the primers 5=-ACGTGGTACCCAAA
ATGACAGAAAATCAGCAGCAACTTC-3= and 5=-ACGTGCGGCCGC
CACTTCGCTTCGACGATGGGGGGC-3=. PCR products were cloned
into the Acc65I andNotI restriction sites of pAc5.1-V5-His-Ntag (47). To
detect expression of V5-taggedMoNV protein,Western blotting was per-
formed using a monoclonal mouse anti-V5 antibody (Invitrogen) and
IRDye 680 goat anti-mouse IgG (Li-Cor Biosciences) for detection on the
Odyssey infrared imager (Li-Cor Biosciences).
To generate bacterial expression plasmids, MoNV B2 was PCR ampli-
fied us ing the pr imers 5 =-ACGTGGATCCATGACAGAA
AATCAGCAG-3= and 5=-ACGTAAGCTTTCACTTCGCTTCGACGATG
G-3= and cloned into the BamHI and HindIII restriction sites of pMal-
C2X (New England BioLabs).
RNAi reporter assays. RNAi reporter assays were performed as de-
scribed earlier (47, 57, 70). Briefly, for double-stranded-RNA (dsRNA)
feeding assays, S2 R cells were seeded, and pMT-Luc, pMT-Ren, and
VSR expression plasmids were transfected the next day. Three days after
transfection, dsRNA targeting firefly luciferase (FLuc) or, as a nonsilenc-
ing control, GFPwas added to the culturemedium to a final concentration
of 20 ng/	l. Expression of the reporters was induced with 0.5mMCuSO4,
and luciferase reporter activity was quantified using the dual-luciferase
reporter system (Promega). Sequential transfection of siRNAs in S2 cells
was described previously (57). S2 cells were seeded at a density of 2.5
 105
cells per well in a 24-well plate, and 1 day later, 300 ng of VSR expression
plasmid or control vector along with 100 ng of pCo-BLAST (Life technol-
ogies) was transfected using the transfection reagent Effectene (Qiagen).
After 48 h, the cells were split 1:5 and transferred to a 96-well plate in
blasticidin-containing Schneider’smedium (final concentration of 25	g/
ml) to select for VSR-expressing cells and 1 day thereafter transfectedwith
siRNA targeting Fluc (version GL3; Dharmacon) or negative-control
siRNA (Qiagen) along with an empty carrier plasmid (pAc5.1-V5-His-
Ntag) using Effectene. Expression of the reporter plasmids was induced
with CuSO4 1 day after the second transfection, and luciferase activities
were measured the day after.
For RNAi reporter assays in infected mosquito cells, U4.4 cells were
seeded at a density of 1
 105 cells per well in a 24-well format. The next
day, cells were mock infected or infected with MoNV at an MOI of 10. At
2 dpi, the cells were transfected with 250 ng of pMT-Luc, 250 ng pMT-
Ren, and either 10 ng of FLuc or GFP dsRNA (dsRNA-initiated RNAi) or
8.1	l of a 20	Mstock of siRNA targetingGL3 (Dharmacon) or negative-
control siRNA (Qiagen) (siRNA-initiated RNAi) using Xtreme Gene HP
reagent (Roche). The same day, expression of the reporter plasmids was
induced, and luciferase activity was measured 18 h later.
Production of recombinant mosinovirus B2 in Escherichia coli.
MBP fusion proteins were purified from E. coli as described earlier (47).
pMAL-MoNV B2 and pMAL-C2X were transformed into competent
BL21 cells. Liquid cultures were grown to an optical density at 600 nm
(OD600) of 1.3, and protein expression was induced with IPTG (isopro-
pyl--D-thiogalactopyranoside) at a final concentration of 1 mM. Cul-
tures were incubated overnight at 18°C, and recombinant proteins were
isolated the next day using amylose resin according to the manufacturer’s
instructions (New England BioLabs). Purified recombinant proteins were
dialyzed against dialysis buffer (20 mM Tris-HCl, 0.5 mM EDTA, 5 mM
MgCl2, 1 mM dithiothreitol [DTT], 140 mM NaCl, 2.7 mM KCl) and
stored in aliquots in dialysis buffer containing 30% glycerol at80°C.
Radioactively labeled probes. The siRNA (Let-7 guide [5=-UGAGGU
AGUAGGUUGUAUAGU-3=] and Let-7 passenger [5=-UAUACAAC
CUACUACCUCUCU-3=]) and blunt dsRNA (F [5=-UAUACAACCUAC
UACCUCUCU-3=] and R [5=-UAUACAACCUACUACCUCUCU-3=])
probes were annealed and end labeled using [-32P]ATP and polynucle-
otide kinase (Roche). Unincorporated nucleotides were removed onG-25
Sephadex columns (Roche). Radioactively labeled dsRNAwas prepared as
described earlier (47, 48).
Electrophoretic mobility shift assays (EMSAs). Gel mobility shift as-
says were performed as described before (47, 48). Briefly, 32P end-labeled
21-nt siRNA duplexes and 21-nt blunt dsRNA (both at a final concentra-
tion of 1 nM per reaction) or uniformly 32P-labeled 126-nt dsRNA (5 ng
per reaction) were incubated with different concentrations of purified
recombinant proteins in binding buffer (5 mM HEPES, 25 mM KCl, 2
mM MgCl2, 3,8% glycerol) and 10 mg/ml tRNA (Roche) for 60 min at
room temperature. EMSAs with 21-nt siRNA and blunt dsRNA were an-
alyzed on an 8% native polyacrylamide gel at 4°C, whereas EMSAs with
126-nt labeled dsRNAs were analyzed on a 6% native gel. Radioactive gels
were imaged by exposure to Kodak Biomax XAR films.
Dicer assay. Dicer assays were performed as described before (47, 57).
Briefly, U4.4 cell lysates were prepared using 30 mM HEPES-KOH (pH
7,4), 100 mM potassium acetate (KOAc), 2 mM Mg(OAc)2, 5 mM DTT,
1
 protease inhibitor (Roche). Uniformly 32P-labeled 126-nt dsRNA (5
ng per reaction) was incubatedwithMoNV-infectedU4.4 cell lysate, non-
infected cell lysate, andmixtures thereof in different proportions for 3 h at
28°C. Samples were then deproteinized using proteinase K (Life Technol-
ogies), extracted with phenol-chloroform, precipitated in the presence of
glycogen (Life Technologies), resuspended in loading buffer II (Life Tech-
nologies), and analyzed on a 12% polyacrylamide–7 M urea gel.
Nucleotide sequence accession numbers. MoNV sequences were
deposited in GenBank under the accession numbers KJ632942 and
KJ632943.
RESULTS
Mosinovirus contains a bipartite genome. Mosquitoes were
sampled in a survey of mosquito-associated viruses in and around
Novel Mosquito-Associated Nodavirus
November 2014 Volume 88 Number 22 jvi.asm.org 13449
 o
n
 M
arch 6, 2017 by UNIVERSITEITSBIBLIO
THEEK
http://jvi.asm.org/
D
ow
nloaded from
 
the Taï National Park, Côte d’Ivoire (64), and MoNV was subse-
quently isolated from a pool of 4 Culicidae sp. mosquitoes
(MoNV/C36/CI/2004) in C6/36 cells. Among the 116 mosquito
pools that induced CPE in C6/36 cells, we detected MoNV repli-
cation by specific real-time RT-PCR in two further pools consist-
ing of 2 Culex nebulosus (MoNV/C37/CI/2004) mosquitoes and 4
Culex sp. mosquitoes (MoNV/D25/CI/2004). Growth of MoNV
was investigated on the vertebrate cell lines Vero E6 and BHK-J.
Cells were infected at MOIs of 0.01 and 0.11, and viral genome
copies in the cell culture supernatants were measured at 1 hpi and
7 dpi. The number of viral genome copies decreased over time
(data not shown), suggesting that MoNV is an insect-specific
virus.
Virions of pooled MoNV/C36/CI/2004 were concentrated via
ultracentrifugation and prepared for next-generation sequencing.
Two separate contigs of 2.964 kb and 363 nt were generated by de
novo assembly. Initial comparisons of the large and small contigs
to the public database (BLASTp, GenBank, NCBI) yielded low but
significant similarities to the RdRp protein of members of the
family Nodaviridae (query coverage, 14 to 93%; E value, 1e-23 -
0.0; identity, 28 to 44%) and to the capsid protein of the mono-
partite LSV (query coverage, 56 to 66%; E value, 0.37 - 0.003;
identity, 32 to 34%), respectively. Attempts to combine these two
contigs with specific primers by PCR failed, suggesting that the
MoNV genome is segmented. This was confirmed by Northern
blotting (see below). The termini of the two genome segments
were determined using 5= and 3= RACE PCR, and the sequences
of both RNA strands were confirmed by specific PCR and
Sanger sequencing.
The entire genome of MoNV comprised 2,972 nt (RNA 1) and
1,801 nt (RNA 2). RNA 1 contains in positive-sense orientation
three overlapping ORFs of 2,883 nt (ORF1), 174 nt (ORF2) and
261 nt (ORF3) (Fig. 1A). Maximal pairwise identity of 43% of the
amino acid sequence of ORF1was found to the RdRp of Pariacoto
virus (PaV) suggesting that ORF1 encodes the MoNV RdRp. We
were unable to identify proteins with homology to MoNVORF2-
FIG 1 Genome organization, viral transcripts, and structural proteins ofMoNV. (A) Schematic organization of the two genome segments. Open reading frames
(ORF) are shown by boxes, and sizes of ORFs are indicated by nucleotide positions. Specific probes for Northern blot analyses are shown by gray bars and
numbered 1 to 3. Genome positions of the subgenomic RNAs are indicated by arrows. (B) Northern blot analysis of viral RNA isolated from MoNV-infected
C6/36 cells at 1 dpi (). Specific DIG-labeled probes (1 to 3) were used for detection. RNA from uninfected C6/36 cells () was used as a mock control. A
DIG-labeled RNAwas used as a sizemarker, and sizes (in nucleotides) are on the left. (C) SDS-PAGE analysis ofMoNVmajor structural proteins. Virus particles
from cell culture supernatants of infected C6/36 cells were purified by gradient ultracentrifugation. Proteins were stained with Coomassie blue R-250. A
molecular mass marker with corresponding sizes is shown on the left.
Schuster et al.
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and ORF3-encoded proteins among the nonredundant protein
sequence database using BLAST searches. RNA 2 contains one
ORF of 1,491 nt (496 amino acids [aa]). The highest pairwise
identity found, 16%, was to the capsid protein of LSV2, suggesting
that RNA 2 encodes the MoNV capsid protein. Like LSV2, the
C-terminal part of the putative capsid protein showed similarity
to the peptidase family A21 (Pfam PF03566). In contrast, the cap-
sid protein of nodaviruses showed similarity to the peptidase fam-
ily A6 (Pfam PF01829).
Mosinovirus acquired its capsid gene from a virus beyond
the family level. To deduce the evolutionary history ofMoNV, we
performed phylogenetic analyses based on the deduced amino
acid sequences of the RdRp and capsid proteins. Based on the
RdRp phylogeny, MoNV clustered in a clade that comprises PaV,
WhNV, andHzAM1-derived virus (HzNV) within the familyNo-
daviridae, suggesting thatMoNV is a novel nodavirus species (Fig.
2A). Unexpectedly, in phylogenetic analyses based on capsid pro-
teins, MoNV branched from a deep node that shared the most
recent common ancestor with LSV1 and LSV2 (Fig. 2B). Given the
extreme divergence of the capsid protein sequences, it was not
possible to generate sufficiently resolved phylogenetic trees that
include all nodavirus species in the analysis. However, maximum
likelihood analyses using only the capsid protein sequences of rep-
resentative nodaviruses showed that MoNV significantly
branched from a deep node together with LSV1 and LSV2 (Fig.
2C). Notably, MoNV is placed between the monopartite LSV and
the bipartite CBPV. These analyses suggest either that MoNV is a
nodavirus that acquired its capsid protein from a virus with a
distant relationship to LSV or that MoNV belongs to an unclassi-
fied virus family that acquired its RdRp and RNAi inhibitor pro-
tein (see below) from nodaviruses. It is widely accepted to inves-
tigate the origin and evolution of viruses based on the
relationships of their replicative genes and to classify viruses based
on these genes (71–73). According to this classification system, the
phylogenetic data suggest that MoNV is a novel member of the
family Nodaviridae that most likely acquired its capsid gene via
reassortment from an unknown virus beyond the family level. In
contrast to this widely applied classification system, nodaviruses
are classified on the basis of, besides virion and genome organiza-
tion, the genetic relationship of their capsid genes (20). To aid in
taxonomic classification, we next investigated morphological and
molecular characteristics ofMoNV that are relevant for virus clas-
sification.
Morphology and structural proteins of mosinovirus. To an-
alyze virion morphology, we purified MoNV by ultracentrifuga-
tion over a sucrose cushion and analyzed virions by negative
staining electronmicroscopy. Like nodaviruses, virions were non-
enveloped and icosahedral. However, the diameter of MoNV vi-
rions was 50 nm, which is much larger than other nodaviruses
(Fig. 3A). This larger virion sizemight be determined by the capsid
protein, which is only distantly related to capsids of members of
the family Nodaviridae (Fig. 2). Analysis of the capsid protein of
purified MoNV virions showed a single protein of56 kDa (Fig.
1C). The molecular mass was slightly higher than the predicted
mass of the protein product of ORF1 of RNA 2 (53.2 kDa), sug-
gesting that thematureMoNV capsid protein does not depend on
cleavage from a precursor protein.
Mosinovirus produces two distinct subgenomic RNAs. To
analyze the viral RNAs that are produced during infection, we
performedNorthern blot analyses on total RNA extracted at 1 dpi
from infected and noninfected C6/36 cells using specific probes
for RNA 1 and RNA 2. For RNA 1, we used two probes that hy-
bridize in different genomic regions. The first probe was placed in
the RdRp-coding ORF1 (Fig. 1A). The second probe was placed at
the 3= end of RNA 1 in ORF3 to analyze if ORF2 and ORF3 are
expressed as subgenomic RNAs. As expected, one band of approx-
imately 1.8 kb was observed for RNA 2, and one band of2.9 kb
was detected using the probe specific for the putative RdRp ORF
(Fig. 1B,  lanes). These bands were specific, as no signal was
observed in RNA from noninfected cells (Fig. 1B, lanes). Using
the probe for the 3= region of RNA 1, we detected three distinct
RNAs: the 2.9-kb full-length RNA 1, as well as two additional
subgenomicRNAs (RNA3, of600 nt, andRNA4, of350 nt) of
approximately the same intensity (Fig. 1B). To determine the
transcription start site of the subgenomic RNAs, we performed
specific 5= RACE on the capped mRNA from infected cells using
specific primers for ORF2 and -3. Analysis of sequenced clones
suggested that subgenomic RNA 3 starts at genome position 2393
with the sequence 5=-GTGAAGAGAC, whereas subgenomic RNA
4 begins further downstream at position 2618 with the sequence
5=-GTGTAATCGC (Fig. 1A). These transcription start sites of the
subgenomic RNAs are located 24 and 27 nt upstream of the start-
codon of the potential ORF2 and -3, respectively. Our data indi-
cate thatMoNV expresses two distinct subgenomic capped RNAs,
predicted to encode 6.8- and 9.8-kDa proteins.
Mosinovirus suppresses RNAi.MoNVwas initially isolated in
the Dicer-2-defectiveAedes albopictusC6/36 cell line and grows to
a titer of 4
 106 TCID50/ml in these cells.We thus compared viral
growth in C6/36 cells to that in the RNAi-competent U4.4 cell line
derived from the samemosquito species. C6/36 cells infected with
MoNV showed stretching and aggregation of cells at three dpi
(Fig. 3B). CPE of MoNV in U4.4 cells was similar but less pro-
nounced at that time point and did not increase at 5 dpi (Fig. 3C).
CPE of MoNV in U4.4 was observed daily until 8 dpi but did not
increase further. Viral RNA in the supernatants of both cell lines
was measured by real-time RT-PCR over a period of 5 days. Con-
centrations of genome copies increased approximately 1,000-fold
in both cell lines within the first 24 hpi (Fig. 3D). From day 2 to 5,
the increase of viral RNA concentrations was between 100- and
10-fold lower inU4.4 cells thanC6/36 cells, suggesting thatMoNV
is targeted by the mosquito RNAi machinery. We thus hypothe-
sized that MoNV evolved mechanisms to suppress or evade the
antiviral RNAi machinery to ensure efficient replication.
We used a well-established RNAi reporter assay to determine if
MoNV inhibits the RNAi pathway in mosquito cells (47, 57, 70).
To this end, we analyzed how MoNV infection affects the effi-
ciency of RNAi-mediated silencing of a firefly luciferase (FLuc)
reporter in U4.4 cells. We transfected mock- or MoNV-infected
U4.4 cells with a FLuc reporter plasmid along with dsRNA target-
ing FLuc (dsFLuc), aswell as aRenilla luciferase (RLuc) expression
plasmid for normalization purposes. The FLuc reporter was effi-
ciently silenced (80-fold) in mock-infected cells. In MoNV-in-
fected cells, however, silencing of FLuc was reduced 10-fold,
suggesting that MoNV suppresses dsRNA-induced RNAi (Fig.
4A). To bypass Dcr-2-dependent cleavage of dsRNA into siRNAs,
we induced RNAi by transfection of siRNAs (siFLuc) along with
the reporter plasmids. In mock-infected cells, the FLuc reporter
was efficiently silenced (10-fold), but MoNV infection com-
pletely abolishedRNAi-mediated silencing (Fig. 4B). These results
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indicate that MoNV is able to suppress the host RNAi response
induced by long dsRNA as well as siRNAs.
Mosinovirus B2 protein inhibits RNAi. Nodaviruses encode
on their subgenomic RNA 3 the B2 protein, which was shown to
function as a potent VSR for some family members (30, 31, 74–
76). MoNV expresses two subgenomic RNAs, RNA 3 and RNA 4,
which are predicted to encode 6.8- and 9.8-kDa proteins, respec-
tively (Fig. 1 and 4). No significant identity or similarity exists
between these predicted proteins and the VSRs of other nodavi-
ruses.We thus analyzed whether either subgenomic RNA encodes
a VSR that would explain the RNAi-suppressive activity in in-
fected cells. We generated expression plasmids encoding V5
epitope-tagged ORF2- and ORF3-encoded proteins. Expression
of theORF3-encoded protein was confirmed byWestern blotting,
but we were unable to stably express the ORF2-encoded protein
(data not shown). We thus tested whether the MoNV ORF3-en-
coded protein suppresses RNAi using reporter assays in Drosoph-
ila S2 cells.We observed that FLucwas silenced (11-fold) in cells
that were transfected with the vector control (Fig. 4C). However,
RNAi-mediated silencing of FLuc was abolished in cells express-
ing MoNV ORF3. The positive control, the cricket paralysis virus
1A protein (CrPV 1A) (32, 58), suppressed RNAi to a similar
extent. Based on these results and results from biochemical assay
(discussed below), we propose that ORF3 encodes a MoNV B2-
like RNAi suppressor.
Next, we performed an RNAi reporter assay in which FLuc was
silenced by sequence-specific siRNA. In this assay, FLuc expres-
sion was efficiently silenced (100-fold), both in control cells and
in cells expressingMoNVB2, suggesting that B2 does not suppress
siRNA-initiated RNAi (Fig. 4D). In contrast, the positive control
Nora virus VP1, which suppresses AGO2-mediated Slicer activity
(47, 59), efficiently abolished RNAi-mediated silencing. Our re-
FIG 2 Phylogenetic relationship of MoNV. Phylogenies were investigated for the RdRp (A) and the capsid protein, including all nodaviruses (B) or represen-
tative nodaviruses only (C). Maximum likelihood (ML) analyses were performed on all sites of an alignment guided by the Dayhoff substitution matrix using
MEGA v5. Bootstrap values are given at nodes and are based on 1,000 bootstrap replicates. Bars indicate evolutionary substitutions. The virus-host associations
are highlighted by color and represented by symbols in the top right corner. Members of the familyNodaviridae are shaded in gray. Themonosegmented viruses
LSV1 and LSV2 are shaded in green. Abbreviations and GenBank accession numbers (in parentheses) for RNA 1 and 2 are as follows: AACV, anopheline-
associated C virus (KF298264, KF298265); ANV, Drosophila melanogaster American nodavirus (GQ342965, GQ342966); BFNNV, barfin flounder nervous
necrosis virus (NC_013458, NC_013459); BGANV, bat guano-associated nodavirus (HM228873); BoV, Boolarra virus (NC_004142, NC_004145); CBPV,
chronic bee paralysis virus (NC_010711, NC_010712); FHV, Flock House virus (NC_004146, NC_004144); HzNV, HzAM1-derived virus (GU976287,
GU976286); LeBlaNV, Le Blanc nodavirus (JQ943579); LSV1, Lake Sinai virus 1 (HQ871931); LSV2, Lake Sinai virus 2 (HQ888865); MoNV, mosinovirus
(KJ632942, KJ632943); MrNV, Macrobrachium rosenbergii nodavirus (NC_005094, NC_005095); NoV, nodamura virus (NC_002690, NC_002691); OrsNV,
Orsay nodavirus (HM030970); PaV, Pariacoto virus (NC_003691, NC_003692); PvNV, Penaeus vannamei nodavirus (NC_014978, NC_014977); RGNNV,
red-spotted grouper nervous necrosis virus (NC_008040, NC_008041); SanNV, Santeuil nodavirus (NC_015069); SJNNV, striped jack nervous necrosis virus
(NC_003448, NC_003449); WhNV, Wuhan nodavirus (AY962576, DQ233638).
FIG 3 Morphology and growth of MoNV. (A) Morphology of MoNV virions. Viral particles from C6/36 infected-cell-culture supernatants were purified by
ultracentrifugation through a 36% sucrose cushion and analyzed by negative-stain electron microscopy. (B) Cytopathic effects of C6/36 cells at 4 days postin-
fection (dpi) with MoNV. (C) Cytopathic effects of U4.4 cells at 5 dpi. (D) Growth of MoNV in C6/36 and U4.4 cells. Cells were infected at an MOI of 0.001
TCID50 per cell in two independent replicates. Genome copies per milliliter of cell culture supernatant were measured by specific RT-PCR at the indicated time
points postinfection.
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sults therefore indicate that MoNV B2 inhibits the RNAi pathway
at a step before RISC-mediated target RNA cleavage. Unexpect-
edly, we observed that siRNA-initiated RNAi is suppressed in in-
fected cells but not in cells expressing B2 protein from a plasmid
(compare Fig. 4B to Fig. 4D), suggesting that another factor in
MoNV-infected cells is required for suppression of siRNA-initi-
ated RNAi.
Mosinovirus B2 possesses dsRNA binding activity. Viral
RNAi antagonists may target different steps in the RNAi pathway,
including Dicer-mediated processing of dsRNA, incorporation of
siRNA into RISC, or RISC-mediated cleavage of target RNA (34,
77). To determine whether MoNV B2 binds dsRNA, we per-
formed electrophoretic mobility shift assays (EMSAs) using re-
combinant maltose-binding protein (MBP)-tagged MoNV B2
protein. Binding of B2 to dsRNA in a dose-dependentmannerwas
observed (Fig. 5A, lanes 3 to 12). B2 completely shifted the dsRNA
at concentrations of 5 	M and higher (Fig. 5A, lanes 3 and 4),
whereas a partial shift was observed at concentrations ranging
from 156 nM to 2.5 	M (Fig. 5A, lanes 5 to 9). As expected, no
shift in dsRNA mobility was observed in the presence of MPB
alone (Fig. 5A, lane 2).
We next analyzed binding of MoNV B2 to 21-nt siRNA by
EMSA. We observed inefficient binding of MoNV B2 protein to
siRNA, with only a partial shift at the highest concentration tested
(21.5 	M) (Fig. 5B, lane 1) but not at lower concentrations (lanes
2 to 4). To analyze whether siRNA binding depends on the 3=
terminal overhang, we analyzed 21-nt blunt dsRNAs by EMSA
and observed that MoNV B2 binds blunt 21-nt dsRNAmore effi-
ciently than siRNAs, with complete shifts at the highest concen-
trations of B2 (21.5	Mand 10	M) (Fig. 5B, lanes 7 and 8) and a
partial shift at 2.5	M(lane 9). Again,MBP did not shift siRNA or
blunt 21-nt dsRNA (Fig. 5B, lanes 5 and 11). Collectively, these
results indicate that MoNV B2 efficiently binds long dsRNA,
which suggests that B2 interferes with processing of dsRNA by
Dcr-2. Moreover, the low affinity of B2 for siRNAsmight account
for its inability to suppress siRNA-mediated RNAi in reporter
assays (Fig. 4D).
Mosinovirus B2 prevents dsRNA cleavage by Dicer. We next
tested whether MoNV inhibits Dcr-2-mediated processing of
dsRNA into siRNAs in cell extracts. To this end, we preparedU4.4
cell lysates from bothMoNV-infected andmock-infected cells. As
reported before (78), radiolabeled dsRNAwas readily processed in
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FIG 4 MoNV B2 suppresses RNAi. (A) dsRNA-initiated RNAi reporter assay in mock- or MoNV-infected U4.4 cells. Cells were mock infected or infected with
MoNV (MOI 10) and transfected at 48 hpi with reporter plasmids encoding firefly luciferase (FLuc) and Renilla luciferase (RLuc) along with FLuc-specific
dsRNA (dsFLuc) or nonspecific control dsRNA (dsCtrl). (B) siRNA-initiated RNAi reporter assay in mock- or MoNV-infected U4.4 cells. FLuc expression was
silenced by transfection of FLuc-specific siRNA (siFLuc) or control siRNA (siCtrl) along with FLuc and RLuc reporter plasmids. (C) dsRNA-initiated RNAi
reporter assay in S2 R cells expressing MoNV B2 or CrPV 1A or in cells transfected with empty control vector, as indicated. RNAi was induced by addition of
dsFLuc or dsCtrl to the culture supernatant at 48 h after transfection. (D) siRNA-initiated RNAi reporter assay in S2 R cells expressingMoNVB2 orNora virus
VP1 or in cells transfected with empty control vector as indicated. RNAi was induced by transfection of siFLuc or siCtrl at 72 h after transfection of luciferase
reporter plasmids and plasmids encoding the VSRs. Firefly luciferase counts were normalized using Renilla luciferase counts, and data are expressed as silencing
(fold) compared to dsCtrl (A and C) or siCtrl (B and D). Data are means and standard deviations (SD) for 3 biological replicates. *, P  0.05; ***, P  0.005
(Student’s t test). NS, not significant.
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extracts from noninfected U4.4 cells (Fig. 6A, lane 5). In contrast,
dsRNA processing into siRNAs was inefficient in extracts from
MoNV-infected cells (Fig. 6A, lane 1). Titrating the MoNV-in-
fected extract into the noninfected extract resulted in a dose-de-
pendent decrease in processing of dsRNA into siRNAs (Fig. 6A,
lanes 2 to 4). These results suggest that MoNV infection prevents
processing of dsRNA into siRNAs. We next performed Dicer as-
says using recombinant MoNV B2 protein to directly analyze
whether B2 is responsible for inhibition of dsRNA cleavage by
Dcr-2. Indeed, we observed that MoNV B2 was able to efficiently
inhibit the processing of dsRNA into siRNAs in a dose-dependent
manner (Fig. 6B, lanes 3 to 5).
DISCUSSION
In this study, we discovered and characterized a previously un-
known virus that was isolated from tropicalCulicidaemosquitoes.
The tentatively named MoNV shares characteristic features with
nodaviruses, such as nonenveloped icosahedral virions, a bipartite
genome of positive-sense RNA segments of 2.9 and 1.8 kb, similar
genome organization, and functions of encoded proteins.
We showed that MoNV encodes two distinct sgRNAs, one en-
coding a B2-like VSR and the other potentially encoding an 7-
kDa protein with unknown function. No evidence for the expres-
sion of more than one subgenomic RNA has been described for
nodaviruses, including PaV, the closest relative of MoNV (25).
However, the RNA bands of lower mobility that appeared on
Northern blots when probes for the subgenomic RNA 3were used
were proposed to be homodimers of sgRNA 3 in other nodavi-
ruses (79, 80).
We demonstrated thatORF3 encodes a potent dsRNA-binding
VSR that inhibits the dsRNA-initiated RNAi pathway and inhibits
processing of dsRNA into siRNAs by Dicer. Unexpectedly, we
observed that siRNA-initiated RNAi is efficiently suppressed in
infected cells but not in cells expressing B2 from an expression
plasmid. The reason for this discrepancy remains unresolved. Al-
though differences in expression levels in infection versus trans-
fection might account for this difference, our observation that B2
only inefficiently binds siRNAs suggests that another viral factor
or interaction ofMoNVB2with other viral proteins is required for
suppression of siRNA-initiated RNAi in infected cells.
The mechanism of VSR activity of MoNV B2 is similar to that
of B2 proteins of alphanodaviruses and betanodaviruses, includ-
ing FHV, Nodamura virus (NoV), and greasy grouper nervous
necrosis virus (GGNNV), as well as the unclassified WhNV (30,
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FIG 5 MoNV B2 binds long dsRNA and siRNAs. (A) Electrophoretic mobility shift assay (EMSA) with 126-nt dsRNA. Uniformly radiolabeled 126-nt dsRNA
was incubated with buffer (lane 1), MBP (10 	M, lane 2), or decreasing concentrations of recombinant MBP-B2 (2-fold dilutions starting at 10 	M [lanes 3 to
12]). (B andC) EMSAwith 21-nt siRNA (B) and 21-nt blunt dsRNA (C). Radiolabeled siRNAs (lanes 1 to 6) or 21-nt blunt dsRNA (lanes 7 to 12) were incubated
with MBP (10 	M [lanes 5 and 11]), buffer (lanes 6 and 12), or decreasing concentrations of recombinant MBP-B2 (lanes 3 to 6 and 9 to 12). For MBP-B2, the
following concentrations were used: 21.5 	M (lanes 1 and 7), 10 	M (lanes 2 and 8), 2.5 	M (lanes 3 and 9), and 0.625 	M (lanes 4 and 10).
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FIG 6 MoNV B2 inhibits Dcr processing of dsRNA. (A) Processing of 126-nt
dsRNA in extracts of noninfected or MoNV-infected U4.4 cells. Uniformly
radiolabeled dsRNAwas incubated in lysate ofMoNV-infectedU4.4 cells (lane
1), noninfected U4.4 lysate alone (lane 5), or mixtures of mock- and MoNV-
infected lysates (lanes 2 to 4, ratios of 3:1, 2:2, and 1:3, respectively). (B) Dicer
assay in lysates of U4.4 cells in the presence of decreasing concentrations of
MBP-B2 fusion protein (5-fold dilutions starting at 5	M[lanes 3 to 5]). MBP
was used as a negative control (5 	M [lane 2]).
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31, 53, 54, 74–76, 81, 82). Although FHV and NoV B2 share only
low sequence identity, these proteins fold into similar structures,
consisting of a four-helix bundle capped by two short helices at the
C-terminal ends (53, 54, 83). Furthermore, 50% of the 10 amino
acid residues interacting with the RNA are identical between FHV
and NoV B2 proteins (83), suggesting that these proteins share an
ancestor.
The MoNV B2 protein shares only minimal sequence identity
to B2 proteins of nodaviruses (27.1% amino acid identity to PaV
and 20.5% amino acid identity toWhNV, but the protein does not
align to B2 of more distant nodaviruses). Since its position in the
genome, its expression strategy, and itsmechanism of action seem
similar to those of the B2 proteins of other nodaviruses (30, 31, 81,
84, 85), the most parsimonious explanation is that the B2 protein
evolved orwas present at the nodavirus ancestor. Interestingly, the
Caenorhabditis elegans-specific nodaviruses do not express an
sgRNA or a B2-like VSR (18), indicating that B2 evolved in the
ancestor of the alpha, beta, and MoNV clades of nodaviruses.
In phylogenetic analyses based on the RdRp gene, MoNV
formed a well-supported sister taxon to Pariacoto virus, suggest-
ing that MoNV is a novel nodavirus species. However, the MoNV
capsid proteinwas not related to nodaviruses, and amaximal pair-
wise identity of 18% to the capsid proteins of two unclassified
viruseswith a nonsegmented genome, LSV1 andLSV2,was found.
Maximum likelihood analyses of the capsid proteins confirmed
this relationship and showed that MoNV shares its most recent
common ancestor (MRCA) with LSV1 and LSV2. These widely
differing phylogenetic relationships of the MoNV RdRp and cap-
sid proteins complicate its taxonomic classification.
Two hypotheses have been proposed to study the origin and
evolution of viruses. The first and most widely accepted hypothe-
sis classifies viruses based on the phylogenetic relationship of their
replicative proteins (71, 72). Importantly, replicative proteins are
sufficiently conserved to produce reliable alignments and thus to
generate robust phylogenetic trees. Furthermore, whereas all RNA
viruses encode replicative enzymes, some viruses do not in general
encode capsid proteins, others may have lost their capsid proteins
during adaption to new hosts, and in others, capsid proteins can
be horizontally transferred, whichmakes virus classification based
on capsids impractical (71). The second, more controversial hy-
pothesis proposes that the evolution of viruses is more accurately
reflected by the virion architecture and consequently by the rela-
tionship of the capsid proteins (86). However, this seems not to be
adequate for parsimonious reconstructions of RNA virus evolu-
tion (72).
Our results indicate that MoNV shares more characteristics
with nodaviruses than with LSV1 and LSV2, suggesting that
MoNV is likely an atypical member of the familyNodaviridae that
acquired its capsid horizontally from a coinfecting LSV-like virus.
The coinfected host may have been a bee or a mosquito, as the
related LSV and CBPV are both detected in bees and AACV is
found in mosquitoes (6–8).
Our data suggest that the capsid protein can be horizontally
transferred between viruses of different families. The acquisition
of structural proteins from viruses beyond the family level seems
to be rare and is limited to viruses that occupy the same ecological
niche and infect the same host. Two recently discovered examples
include the transfer of a capsid gene from a ssRNA virus (Tombus-
viridae) to an ssDNAvirus (circo-like virus) (87, 88) and the trans-
fer of a capsid from parvoviruses to the Bidnaviridae (89). Reas-
sortment and recombination were for a long time believed to
occur only between genetically closely related viruses that showno
more than about 5% distance at the nucleotide level (20, 90–92).
Thus, the ability of two viruses to exchange their genome seg-
ments serves as a general species demarcation criterion. However,
our data and other recent observations (87–89) show that hori-
zontal gene transfer between distantly related viruses plays an im-
portant role in viral evolution.
The ICTV classifies nodavirus species on the basis of the phy-
logenetic relationship of their capsid genes (20). The pairwise
identity of the capsid protein to the most closely related species
should be less than 80% at the nucleotide level and less than 87%
at the amino acid level to classify a virus as a novel species. Thus,
the genera Alphanodavirus and Betanodavirus have been estab-
lished based on the genetic and phylogenetic relationships of the
capsid proteins of their members. Based on this classification sys-
tem,MoNVwould belong to a yet-unknown family.However, it is
more likely that MoNV acquired its capsid gene horizontally as
outlined above. Such horizontal exchanges of capsid genes seem to
be common within the family Nodaviridae (Fig. 2A and B).
Whereas betanodaviruses formwell-supported clades in phyloge-
netic analyses based on their RdRp and capsid sequences, alpha-
nodaviruses are divided into two different clades in phylogenetic
analyses of the RdRp sequences, suggesting thatmultiple reassort-
ment events have occurred. Consequently, we suggest reclassify-
ing nodaviruses based on the relationship of their RdRp genes,
similar to the classification system used for other viral families.
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